#hta — Public Fediverse posts

June garden centre sales impacted by extreme weather and water restrictions https://www.allforgardening.com/1877154/june-garden-centre-sales-impacted-by-extreme-weather-and-water-restrictions/ #garden #GardenCentreSales #HTA

June garden centre sales impacted by extreme weather and water restrictions https://www.allforgardening.com/1877154/june-garden-centre-sales-impacted-by-extreme-weather-and-water-restrictions/ #garden #GardenCentreSales #HTA

HAPS: Гелий, планер и стратосферная базовая станция 6G

Надвигающийся стандарт сотовой связи 6G принесет нам много новинок, которые я уже разбирал подробно. Лично для меня самой внезапной оказалась концепция HAPS. Напомню, что HAPS расшифровывается как High Altitude Platform Station — высотные платформенные станции. Своей сутью это летающие базовые станции, которые могут надолго зависать над определенным районом и обеспечивать его связью. Плюсов от такого подхода прилично. Судите сами. Мы можем оперативно развернуть связь в любой точке земного шара. В горах, на море или там, где произошло стихийное бедствие и наземная инфраструктура связи погребена под руинами. Если сравнивать с космической связью (тем же Старлинком) то HAPS находятся куда ниже низкоорбитальных спутников. Формально в документах Международного союза электросвязи HAPS — это станция на объекте на высоте 20–50 км. На практике большинство сценариев смотрит в сторону стратосферных высот около 20 км: выше погоды и коммерческой авиации, но на порядок ниже спутниковых орбит. Напомню, что типовая LEO-орбита порядка 500 км. А это значит, что мы можем себе позволить меньшие задержки и меньшую мощность передатчика в сотовом телефоне. Получается, одни плюсы. Только вот есть несколько вопросов. А как к HAPS подвести канал связи? А как туда подвести питание? А как создатели 6G вообще себе представляют атмосферный объект, который днями висит на месте и не падает? Что ж, давайте разбираться!

https://habr.com/ru/companies/beget/articles/1047508/

#HAPS #HTA #LTA #беспилотник #дрон #6G #3GPP #Zephyr #StarLink #Loon

Producer-responsibility rules in the EU wastewater directive could become a medicine-access issue, not just an environmental compliance issue. https://www.mattheneus.com/editorial/tlv-wastewater-directive-producer-responsibility-medicine-access-2026-05-13 #HTA #RegulatoryAffairs #Pharma

MAIC evidence for tobacco cessation needs more than balanced baselines: endpoint timing and model inputs have to survive payer scrutiny. https://www.mattheneus.com/editorial/tobacco-cessation-maic-time-window-audit-payer-evidence-2026-05-27 #HTA #MAIC #EvidenceSynthesis #HealthEconomics

TLV’s Yescarta review shows how matched indirect evidence can support access decisions while still leaving major uncertainty for cost-effectiveness. https://www.mattheneus.com/editorial/tlv-yescarta-follicular-lymphoma-zuma5-scholar5-cost-effectiveness-2026-05-22 #HTA #MAIC #Pharma #HealthEconomics

Trial amendments can reset the HTA evidence question, changing what belongs in the assessment and what needs re-justification. https://www.mattheneus.com/editorial/trial-method-amendments-hta-evidence-reset-2026-05-04 #HTA #RegulatoryAffairs #EvidenceSynthesis

Tricuspid valve replacement economics can hinge on one modeling choice: how mortality is extrapolated beyond trial follow-up. https://www.mattheneus.com/editorial/tricuspid-valve-replacement-cost-effectiveness-mortality-extrapolation-2026-05-13 #HTA #HealthEconomics #EvidenceSynthesis

Coverage for adolescent bariatric surgery shows how HTA bodies narrow evidence into reimbursable subgroups. https://www.mattheneus.com/editorial/zin-bariatric-surgery-adolescent-obesity-basic-package-evidence-2026-06-04 #HTA #EvidenceSynthesis #HealthEconomics

TRUSTGUIDES puts recommendation trustworthiness under a sharper evidence-lineage lens for guideline teams. https://www.mattheneus.com/editorial/trustguides-recommendation-trustworthiness-evidence-lineage-2026-05-28 #HTA #EvidenceSynthesis #RegulatoryAffairs

In resource-limited settings, type 1 diabetes access has to account for affordability, capacity, and delivery constraints together. https://www.mattheneus.com/editorial/type-1-diabetes-resource-limited-settings-affordability-capacity-2026-05-15 #HTA #Pharma #HealthEconomics

Ultra-rare disease evidence synthesis needs an agency-method map before payer review. https://www.mattheneus.com/editorial/ultra-rare-disease-evidence-synthesis-agency-method-map-2026-05-12 #HTA #EvidenceSynthesis #RegulatoryAffairs

Emergency chemical-exposure guidance is becoming an implementation and preparedness workflow, not just clinical advice. https://www.mattheneus.com/editorial/who-toxic-chemical-exposure-interim-clinical-guidance-implementation-evidence-2026-06-04 #HTA #EvidenceSynthesis #RegulatoryAffairs

US drug policy pressure is turning evidence strategy into a launch decision: sequencing, pricing exposure, and budget impact now need to be planned together. https://www.mattheneus.com/editorial/us-drug-policy-pressure-evidence-strategy-launch-strategy-ispor-2026 #HTA #HealthEconomics #Pharma

HTA submissions need validated AI workflows with source-linked evidence, human review, and audit-traceable lineage. AbangeLabs HTA Studio is built around that governance problem. https://www.mattheneus.com/editorial/validated-llm-workflows-hta-submissions-ispor-2026 #HTA #EvidenceSynthesis #Pharma

The new WHO AMR action plan turns antimicrobial resistance into an evidence investment strategy, not only a public health priority. #HTA #Pharma #RegulatoryAffairs https://www.mattheneus.com/editorial/who-amr-action-plan-evidence-investment-strategy-2026-05-25

WHO AI policy guidance raises the bar for evidence teams: readiness now means governance, validation, and auditability. #HTA #EvidenceSynthesis #RegulatoryAffairs https://www.mattheneus.com/editorial/who-artificial-intelligence-evidence-informed-policy-readiness-review-2026-06-02

WHO health-for-all economics is a reminder that reimbursement evidence cannot stop at narrow budget impact. #HTA #EvidenceSynthesis #HealthEconomics https://www.mattheneus.com/editorial/who-health-for-all-economics-reimbursement-evidence-ledger-2026-05-23

Precision medicine readiness starts before the dossier: teams need a payer evidence map that links biomarker strategy, comparators, endpoints, and access questions. https://www.mattheneus.com/editorial/who-precision-medicine-payer-evidence-map-2026-05-22 #HTA #EvidenceSynthesis #Pharma

WHO prequalification puts procurement evidence on a clock: access teams need a living file that connects product quality, implementation constraints, and payer expectations. https://www.mattheneus.com/editorial/who-substance-use-prequalification-procurement-evidence-file-2026-06-03 #HTA #Pharma #RegulatoryAffairs

Coverage reversals are often evidence governance failures, not just clinical debates. The Dutch chronic-pain rehabilitation decision shows what happens when key evidence is withdrawn. https://www.mattheneus.com/editorial/zin-imsr-chronic-pain-coverage-evidence-withdrawal-2026-04-20 #HTA #EvidenceSynthesis #RegulatoryAffairs

WHO pharmacovigilance reform is pushing safety evidence teams toward smarter RWE, AI-enabled signal workflows, and clearer regulatory evidence plans. https://www.mattheneus.com/editorial/who-smart-pharmacovigilance-rwe-ai-safety-evidence-strategy-2026-05-24 #HTA #RWE #RegulatoryAffairs

The WHA teleradiology resolution turns remote imaging services into an evidence, governance, and implementation-readiness question for market access teams. https://www.mattheneus.com/editorial/who-teleradiology-resolution-evidence-plan-2026-05-22 #HTA #EvidenceSynthesis #RegulatoryAffairs

Dutch drug assessment timelines are tightening, raising the bar for reimbursement dossier readiness and evidence planning. https://www.mattheneus.com/editorial/zin-sluis-drug-assessment-timelines-2025-faster-reimbursement-dossiers-2026-05-04 #HTA #Pharma #RegulatoryAffairs

TLV’s Myalepta decision shows how rare-disease flexibility still needs subgroup value, severity, and negotiated cost to support reimbursement. https://www.mattheneus.com/editorial/tlv-myalepta-generalised-lipodystrophy-limited-reimbursement-2026-04-25 #HTA #Pharma #RegulatoryAffairs

Sweden’s TLV framed Vevizye as a restricted reimbursement case: comparable effect to Ikervis, equal daily medicine cost, and no implied superiority claim. https://www.mattheneus.com/editorial/tlv-vevizye-ciclosporin-limited-reimbursement-ikervis-cost-comparison-2026-04-28 #HTA #Pharma #RegulatoryAffairs

Trial retention is now an HTA evidence-governance issue: missing outcomes can weaken comparative estimates, utility inputs, and reimbursement models. https://www.mattheneus.com/editorial/trial-retention-outcome-data-completeness-hta-evidence-governance-playbook-2026-04-22 #HTA #NMA #MAIC #EvidenceSynthesis #RegulatoryAffairs

Gold rush for APL member gardens at Harrogate Spring Flower Show https://www.allforgardening.com/1736328/gold-rush-for-apl-member-gardens-at-harrogate-spring-flower-show/ #APL #garden #HarrogateSpringFlowerFestival #HTA

Gold rush for APL member gardens at Harrogate Spring Flower Show https://www.allforgardening.com/1736328/gold-rush-for-apl-member-gardens-at-harrogate-spring-flower-show/ #APL #garden #HarrogateSpringFlowerFestival #HTA

Target trial emulation is getting harder to ignore in HTA: registry-based RWD shifted the ICER for post-first-line RA biologics from ~£34.7k to ~£46.8k/QALY. https://www.mattheneus.com/editorial/target-trial-emulation-rwd-cost-effectiveness-hta-playbook-2026-04-03 #HTA #RWE #HealthEconomics

CAR-T access is no longer just a clinical story; HTA timing and cost-effectiveness design now shape who gets to market and when.

https://www.mattheneus.com/editorial/car-t-global-hta-access-lag-cost-effectiveness-playbook-2026-04-02

#HTA #HealthEconomics #Pharma

The UK just made non-animal evidence planning more real: MHRA’s new advance Module 4 review route gives teams an earlier read on whether their package will hold up. https://www.mattheneus.com/editorial/mhra-non-animal-methods-module-4-advance-review-guidance-2026-04-02 #HTA #RegulatoryAffairs #Pharma

British Garden Centres meet with MP Priti Patel to highlight mounting financial pressures facing the horticultural sector https://www.allforgardening.com/1623812/british-garden-centres-meet-with-mp-priti-patel-to-highlight-mounting-financial-pressures-facing-the-horticultural-sector/ #BritishGardenCentres #garden #HTA

HTA celebrate 20 years of the Garden Press Event https://www.allforgardening.com/1615907/hta-celebrate-20-years-of-the-garden-press-event/ #garden #GardenPressEvent #HTA

Fałszywe repozytoria GitHub z narzędziami OSINT rozprzestrzeniają złośliwe oprogramowanie

Osoby związane z szeroko rozumianym IT, zarządzające systemami czy tworzące oprogramowanie, to szczególnie łakomy kąsek dla grup przestępczych działających w cyfrowym świecie. Nie jest to nowe zjawisko. Tym razem mamy do czynienia z pewną ewolucją. TLDR: Cyberprzestępcy zamiast łamać platformy zdecydowali się uderzyć w nasz najczulszy punkt, jakim jest zaufanie....

#Aktualności #Fileless #Github #Hta #Kryptowaluty #Malware #OSINT #RAT

https://sekurak.pl/falszywe-repozytoria-github-z-narzedziami-osint-rozprzestrzeniaja-zlosliwe-oprogramowanie/

Will I, despite all the angst and disappointment, have managed to include a slide about Sampdoria in my talk on missing data, at tomorrow ISPOR conference session?

Come and find out for yourself... 😉

#HTA #isporEurope #missingdata #bayesianmodelling

Webinar: Making Health Economic Models Shiny — Excel → R & Shiny

Tue Nov 18 · 8am PT / 11am ET / 4pm GMT

Practical migration tips for HTA teams: pitfalls, workflows, reproducibility.

Speakers: Dr Robert Smith, Dr Wael Mohammed (Dark Peak Analytics)

Register: https://r-consortium.org/webinars/making-health-economic-models-shiny.html

#rstats #Shiny #HTA #healthcare

Ejecución sin archivos: cargadores HTA y PowerShell ejecutan RATs https://blog.elhacker.net/2025/05/fileless-remcos-rat-hta-lnk-powershell.html #powershell #fileless #Malware #hta #lnk #rat

European #HTA agencies and the #EMA developed joint positions for better #evidence

A key result of the workshops: Drug studies should be designed in such a way that they address both regulatory questions and the essential research questions of benefit assessments.

Our press release: https://www.iqwig.de/en/presse/press-releases/press-releases-detailpage_143936.html

Europäische #HTA-Agenturen und die #EMA erarbeiten gemeinsame Positionen für bessere #Evidenz

Zentrales Ergebnis: Arzneimittelstudien sollten so gestaltet sein, dass sie sowohl Zulassungsfragen als auch die wesentlichen Fragen der Nutzenbewertung klären.

Unsere Meldung: https://www.iqwig.de/presse/pressemitteilungen/pressemitteilungen-detailseite_143936.html

#EbM

SideWinder targets the maritime and nuclear sectors with an updated toolset – Source: securelist.com https://ciso2ciso.com/sidewinder-targets-the-maritime-and-nuclear-sectors-with-an-updated-toolset-source-securelist-com/ #rssfeedpostgeneratorecho #APT(Targetedattacks) #MalwareDescriptions #MalwareTechnologies #CyberSecurityNews #Targetedattacks #Defenseevasion #Windowsmalware #securelistcom #spearphishing #APTreports #JavaScript #SideWinder #shellcode #Malware #.NET #APT #HTA

2025-01-09 (Thursday):

#CVE-2017-0199 Excel (#XLS) file --> #HTA --> #VBS --> #steganography --> #DBatLoader or #GuLoader style malware for #AgentTesla. Data exfil over FTP. A #pcap from an infection, the associated malware, and more info available at www.malware-traffic-analysis.net/2025/01/09/index.html

Cloud Atlas seen using a new tool in its attacks – Source: securelist.com https://ciso2ciso.com/cloud-atlas-seen-using-a-new-tool-in-its-attacks-source-securelist-com/ #rssfeedpostgeneratorecho #MalwareDescriptions #MalwareTechnologies #CyberSecurityNews #Windowsmalware #Cloudservices #securelistcom #CloudAtlas #PowerShell #datatheft #backdoor #Phishing #Telegram #Malware #DLL #HTA #VBS

New release (v. 2.0.2)for #survHE now on CRAN

https://gianluca.statistica.it/software/survhe/

#rstats #HTA #survival

Топ опасных уязвимостей июля. Под угрозой пользователи ОС Windows и Linux

Хабр, привет! Я Александр Леонов, ведущий эксперт лаборатории PT Expert Security Center. Мы с коман­­дой аналитиков Positive Technologies каждый месяц исследуем информацию об уязвимостях из баз и бюллетеней безопасности вендоров, социальных сетей, блогов, телеграм-каналов, баз эксплойтов, публичных репозиториев кода и выявляем во всем этом многообразии трендовые уязвимости. То есть те недостатки безопасности, которые либо уже эксплуатируются вживую, либо могут начать эксплуатироваться в ближайшее время. Сегодня расскажу про самые опасные уязвимости июля. Всего таких уязвимостей было три: 1️⃣ Уязвимость, приводящая к спуфингу, в движке для обработки и отображения HTML-страниц Microsoft Windows MSHTML Platform (CVE-2024-38112). 2️⃣ Уязвимость, связанная с выполнением произвольного кода в интерпретаторе PostScript и PDF-документов Ghostscript (CVE-2024-29510). 3️⃣ Уязвимость, связанная с выполнением произвольного кода в гиперконвергентной [1] платформе Acronis Cyber Infrastructure (CVE-2023-45249). Узнать самые опасные уязвимости июля

https://habr.com/ru/companies/pt/articles/834630/

#трендовые_уязвимости #эксплойт #linux #windows #hta #internet_explorer #ghostscript #metasploit #aci

Jetzt noch mitmachen: Ende Juli endet die diesjährige Einreichungsrunde für unseren ThemenCheck Medizin!

Worum und wie das geht und welche medizinischen Fragen Bürger*innen uns in den jetzten Jahren schon gestellt haben - all das steht hier: https://www.iqwig.de/sich-einbringen/themencheck-medizin/

#HTA #HealthTechnologyAssessment

Registrations are open for the online Health Technology Assessment (HTA) summer workshop the R for Health Technology Assessment Academic Consortium offers! 🌐📊 https://r-hta.org/

Join us to enhance your HTA skills using R. Learn more and register here: https://r-hta.org/events/workshop/2024/

#HTA #HealthTech #RStats #Workshop

Realising the potential of HTA Reform [Promoted content] https://www.euractiv.com/section/health-consumers/opinion/realising-the-potential-of-hta-reform/?utm_source=dlvr.it&utm_medium=mastodon #Accesstomedicines #healthcare #HTA #Innovation #lifesciences

Hot off the press with Spyridon Poulimenos and Jeff Round

https://journals.sagepub.com/doi/abs/10.1177/0272989X241239899

#hta #bayesianMethodsHealthEconomics #utility #uncertainty

https://rerednawyerg.github.io/malwareanalysis/gad_sectoprat_update/

#security #hta #sectoprat

Gemeinsam für hohe Standards bei der Bewertung von Gesundheitstechnologien in Europa ab 2025

Wenige Monate vor Inkrafttreten der #EUHTA-Verordnung besuchte eine Delegation der französischen #HTA-Agentur #HAS das IQWiG in Köln, um sich über die Zukunft der europäischen Nutzenbewertung auszutauschen.

https://www.iqwig.de/presse/pressemitteilungen/pressemitteilungen-detailseite_113368.html

(2/4)

https://linktr.ee/unionistsforpalestine

#U4P #Gaza #union #solidarity for #Palestine #HTA #warprofiteers #antimilitarism

HTA SHUT IT DOWN: NO F-35 CONTRACTS FOR ISRAEL-HTA
https://backlashblogs.wordpress.com/tag/palestine/

The future of surveillance and lethal repression in the open prison #Gaza
https://kolektiva.media/w/hLBzLUtGSRHeHFPZfi5jGU

#Gaza #Palestine #antimilitarism #necropolitics #directaction #HTA #F35 #Campbellfield

It's that time of the year again...
Registration is open for our summer school in Bayesian methods in health economics - in Florence (just saying...). 22-26 July, this year with a slightly changed team. Check all details here:
https://gianluca.statistica.it/teaching/summer-school/

Registration is open here:
http://tinyurl.com/bmhe-24

First-come/first-serve, so hurry up!

#costeffectiveness #bayesian #statistics #hta #modelling #BUGS #mcmc

New Brexit checks ‘pose existential threat’ to UK fruit and flower growers | Brexit | The Guardian
https://www.theguardian.com/politics/2024/jan/22/brexit-checks-existential-threat-uk-fruit-flower-growers

#Brexit
#Fruit
#Flowers
#UK
#Trade
#NFU
#Crops
#EU
#YoungPlants
#Netherlands
#NurseryPlants
#HTA
#BBG
#BTG
#BTOM

Still missing huge parts of our old bubble, especially the international peeps: #medicine, health technology assessment #hta, #EvidenceBasedMedicine. Many scientists, journalists and institutions are still on X, others seem to flock on #bluesky.

https://youtu.be/BN1WwnEDWAM?si=YTpz8mGlre01hwCU